Literature DB >> 19360910

Chronic pancreatitis: maldigestion, intestinal ecology and intestinal inflammation.

Raffaele Pezzilli.   

Abstract

Exocrine pancreatic insufficiency caused by chronic pancreatitis results from various factors which regulate digestion and absorption of nutrients. Pancreatic function has been extensively studied over the last 40 years, even if some aspects of secretion and gastrointestinal adaptation are not completely understood. The main clinical manifestations of exocrine pancreatic insufficiency are fat malabsorption, known as steatorrhea, which consists of fecal excretion of more than 6 g of fat per day, weight loss, abdominal discomfort and abdominal swelling sensation. Fat malabsorption also results in a deficit of fat-soluble vitamins (A, D, E and K) with consequent clinical manifestations. The relationships between pancreatic maldigestion, intestinal ecology and intestinal inflammation have not received particular attention, even if in clinical practice these mechanisms may be responsible for the low efficacy of pancreatic extracts in abolishing steatorrhea in some patients. The best treatments for pancreatic maldigestion should be re-evaluated, taking into account not only the correction of pancreatic insufficiency using pancreatic extracts and the best duodenal pH to permit optimal efficacy of these extracts, but we also need to consider other therapeutic approaches including the decontamination of intestinal lumen, supplementation of bile acids and, probably, the use of probiotics which may attenuate intestinal inflammation in chronic pancreatitis patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19360910      PMCID: PMC2668772          DOI: 10.3748/wjg.15.1673

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  42 in total

1.  Determination of faecal calprotectin, a novel marker of organic gastrointestinal disorders.

Authors:  A G Røseth
Journal:  Dig Liver Dis       Date:  2003-09       Impact factor: 4.088

2.  The role of calprotectin in predicting endoscopic post-surgical recurrence in asymptomatic Crohn's disease: a comparison with ultrasound.

Authors:  A Orlando; I Modesto; F Castiglione; L Scala; D Scimeca; A Rispo; S Teresi; F Mocciaro; V Criscuoli; C Marrone; P Platania; T De Falco; S Maisano; N Nicoli; M Cottone
Journal:  Eur Rev Med Pharmacol Sci       Date:  2006 Jan-Feb       Impact factor: 3.507

3.  Fecal pancreatic elastase: a reproducible marker for severe exocrine pancreatic insufficiency.

Authors:  Satoru Naruse; Hiroshi Ishiguro; Shigeru B H Ko; Toshiyuki Yoshikawa; Takeshi Yamamoto; Akiko Yamamoto; Sachiko Futakuchi; Hidemi Goto; Yukio Saito; Susumu Takahashi
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

4.  Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease.

Authors:  Renata D'Incà; Elisabetta Dal Pont; Vincenza Di Leo; Antonio Ferronato; Walter Fries; Maria Grazia Vettorato; Diego Martines; Giacomo Carlo Sturniolo
Journal:  Int J Colorectal Dis       Date:  2006-07-13       Impact factor: 2.571

5.  Faecal calprotectin in children with chronic gastrointestinal symptoms.

Authors:  Alan Bremner; Sohere Roked; Rebecca Robinson; Ian Phillips; Mark Beattie
Journal:  Acta Paediatr       Date:  2005-12       Impact factor: 2.299

Review 6.  Using breath tests wisely in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpretation.

Authors:  Joseph Romagnuolo; Dan Schiller; Robert J Bailey
Journal:  Am J Gastroenterol       Date:  2002-05       Impact factor: 10.864

7.  Bile acid malabsorption or disturbed intestinal permeability in patients treated with enzyme substitution for exocrine pancreatic insufficiency is not caused by bacterial overgrowth.

Authors:  Jan Lysgård Madsen; Jesper Graff; Else Kirstine Philipsen; Ole Scharff; Jüri Johannes Rumessen
Journal:  Pancreas       Date:  2003-03       Impact factor: 3.327

8.  Fecal calprotectin and elastase 1 determinations in patients with pancreatic diseases: a possible link between pancreatic insufficiency and intestinal inflammation.

Authors:  Raffaele Pezzilli; Alessandra Barassi; Antonio M Morselli-Labate; Lorenzo Fantini; Paola Tomassetti; Davide Campana; Riccardo Casadei; Sergio Finazzi; Gianvico Melzi d'Eril; Roberto Corinaldesi
Journal:  J Gastroenterol       Date:  2007-09-25       Impact factor: 7.527

Review 9.  Laboratory markers in IBD: useful, magic, or unnecessary toys?

Authors:  S Vermeire; G Van Assche; P Rutgeerts
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

10.  Exocrine pancreatic function assessed by secretin cholangio-Wirsung magnetic resonance imaging.

Authors:  Lucia Calculli; Raffaele Pezzilli; Marta Fiscaletti; Riccardo Casadei; Carla Brindisi; Giampaolo Gavelli
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2008-04
View more
  13 in total

Review 1.  Pharmacological challenges in chronic pancreatitis.

Authors:  Anne Estrup Olesen; Anne Brokjaer; Iben Wendelboe Fisher; Isabelle Myriam Larsen
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

2.  Does the Healthy Eating Index and Mediterranean Diet Score Identify the Nutritional Adequacy of Dietary Patterns in Chronic Pancreatitis?

Authors:  Kristen M Roberts; Paige Golian; Marcia Nahikian-Nelms; Alice Hinton; Peter Madril; Kathleen Basch; Darwin Conwell; Phil A Hart
Journal:  Dig Dis Sci       Date:  2019-02-23       Impact factor: 3.199

Review 3.  Pancreatic enzyme therapy.

Authors:  Joachim Mössner; Volker Keim
Journal:  Dtsch Arztebl Int       Date:  2010-08-29       Impact factor: 5.594

4.  Gastrointestinal symptoms before and after total pancreatectomy with islet autotransplantation: the role of pancreatic enzyme dosing and adherence.

Authors:  Jill Crosby; Melena D Bellin; David M Radosevich; Srinath Chinnakotla; Ty B Dunn; Timothy L Pruett; Martin L Freeman; Greg J Beilman; Sarah J Schwarzenberg
Journal:  Pancreas       Date:  2015-04       Impact factor: 3.327

5.  Association between small intestinal bacterial overgrowth and toll-like receptor 4 in patients with pancreatic carcinoma and cholangiocarcinoma.

Authors:  Xiaoying Ma; Heju Wang; Peng Zhang; Lin Xu; Zibin Tian
Journal:  Turk J Gastroenterol       Date:  2019-02       Impact factor: 1.852

6.  Single dose delta-9-tetrahydrocannabinol in chronic pancreatitis patients: analgesic efficacy, pharmacokinetics and tolerability.

Authors:  Marjan de Vries; Dagmar C M Van Rijckevorsel; Kris C P Vissers; Oliver H G Wilder-Smith; Harry Van Goor
Journal:  Br J Clin Pharmacol       Date:  2016-01-17       Impact factor: 4.335

Review 7.  Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian Association for the Study of the Pancreas.

Authors:  Raffaele Pezzilli; Angelo Andriulli; Claudio Bassi; Gianpaolo Balzano; Maurizio Cantore; Gianfranco Delle Fave; Massimo Falconi
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

8.  Enzyme replacement therapy for pancreatic insufficiency: present and future.

Authors:  Aaron Fieker; Jessica Philpott; Martine Armand
Journal:  Clin Exp Gastroenterol       Date:  2011-05-04

9.  Exocrine Pancreatic Insufficiency Following Gastric Resectional Surgery-is Routine Pancreatic Enzyme Replacement Therapy Necessary?

Authors:  Rajeevan Philip Sridhar; Myla Yacob; Sudipta Dhar Chowdhury; Kunissery A Balasubramanian; Inian Samarasam
Journal:  Indian J Surg Oncol       Date:  2021-04-05

Review 10.  Digestive Enzyme Supplementation in Gastrointestinal Diseases.

Authors:  Gianluca Ianiro; Silvia Pecere; Valentina Giorgio; Antonio Gasbarrini; Giovanni Cammarota
Journal:  Curr Drug Metab       Date:  2016       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.